The terminal differentiation of cytotoxic CD4+ T cells has been described in autoinflammatory disease, the tumor microenvironment, and chronic (or latent) viral infection (Appay et al., 2002; Mattoo et al., 2016; Oh et al., 2020). This evidence concerns the gene CD4 and neoplasm.